Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Malamut

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Pain Medicine (Malden, Mass.)|October 11, 2017
Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid UsersMary Bond, Kerri A Schoedel, Laura Rabinovich-Guilatt, et al.
Clinical Drug Investigation|September 27, 2017
Effect of Food on the Pharmacokinetics of Single- and Multiple-Dose Hydrocodone Extended Release in Healthy SubjectsMary Bond, Laura Rabinovich-Guilatt, Sally Selim, et al.
The Clinical Journal of Pain|March 8, 2017
Safety and Efficacy of a Topical Sodium Channel Inhibitor (TV-45070) in Patients With Postherpetic Neuralgia (PHN): A Randomized, Controlled, Proof-of-Concept, Crossover Study, With a Subgroup Analysis of the Nav1.7 R1150W GenotypeNicola Price, Rostam Namdari, Judith Neville, et al.
The Journal of Pain|August 25, 2016
Participant Preferences for Pharmacologic Chronic Pain Treatment Trial Characteristics: An ACTTION Adaptive Choice-Based Conjoint StudyShannon M Smith, Jennifer S Gewandter, Rachel A Kitt, et al.
Annals of the New York Academy of Sciences|May 9, 2012
Understanding chronic inflammatory and neuropathic painJane P Hughes, Iain Chessell, Richard Malamut, et al.
Pain|July 10, 2012
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendationsDennis C Turk, Alec B O'Connor, Robert H Dworkin, et al.
Pain Reports|May 13, 2021
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|April 19, 2015
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|January 10, 2024
Patient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerationsSimon Haroutounian, Katherine J Holzer, Robert D Kerns, et al.
Pain|May 9, 2024
Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statementDavid Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Pain Medicine (Malden, Mass.)|October 11, 2017
Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid UsersMary Bond, Kerri A Schoedel, Laura Rabinovich-Guilatt, et al.
Clinical Drug Investigation|September 27, 2017
Effect of Food on the Pharmacokinetics of Single- and Multiple-Dose Hydrocodone Extended Release in Healthy SubjectsMary Bond, Laura Rabinovich-Guilatt, Sally Selim, et al.
The Clinical Journal of Pain|March 8, 2017
Safety and Efficacy of a Topical Sodium Channel Inhibitor (TV-45070) in Patients With Postherpetic Neuralgia (PHN): A Randomized, Controlled, Proof-of-Concept, Crossover Study, With a Subgroup Analysis of the Nav1.7 R1150W GenotypeNicola Price, Rostam Namdari, Judith Neville, et al.
The Journal of Pain|August 25, 2016
Participant Preferences for Pharmacologic Chronic Pain Treatment Trial Characteristics: An ACTTION Adaptive Choice-Based Conjoint StudyShannon M Smith, Jennifer S Gewandter, Rachel A Kitt, et al.
Annals of the New York Academy of Sciences|May 9, 2012
Understanding chronic inflammatory and neuropathic painJane P Hughes, Iain Chessell, Richard Malamut, et al.
Pain|July 10, 2012
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendationsDennis C Turk, Alec B O'Connor, Robert H Dworkin, et al.
Pain Reports|May 13, 2021
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|April 19, 2015
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|January 10, 2024
Patient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerationsSimon Haroutounian, Katherine J Holzer, Robert D Kerns, et al.
Pain|May 9, 2024
Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statementDavid Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pageof 3